| Tag | Content |
|---|
EnhancerAtlas ID | HS136-19463 |
Organism | Homo sapiens |
Tissue/cell | Monocyte |
Coordinate | chr8:109479680-109481700 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr8:109480501-109480522 | CTTTACTTTTACTTTTCTTCT | + | 6.53 | | IRF1 | MA0050.2 | chr8:109480806-109480827 | CTAAACTTTCACTTTCATTTC | + | 7.83 | | MNX1 | MA0707.1 | chr8:109480744-109480754 | TTTAATTACC | - | 6.02 | | POU4F2 | MA0683.1 | chr8:109480949-109480965 | ATTCATAATTAATAAG | + | 6.37 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_07618 | chr8:109479760-109485426 | Brain_Hippocampus_Middle_150 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr8 | 109480216 | 109481494 | | chr8 | 109480276 | 109480326 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I108467 | chr8 | 109479831 | 109481828 |
|
Enhancer Sequence | GATTCTCCTG CCTCAGCCTC CCAAGTAGTT GGGATTACAG GTGCACACCA CCACGCTCAG 60
CTAATTTTTT TGTTTGATTT GTGGCATTTG TATGCAATAT TTTCTTTTTT AAAAATGTCT 120
ATTTATTTTT ATTTTTGTAG AGACAGGGTC TCACTATGTT GCCCAGGCTG GTCTCTCACT 180
CCTGGGCTCA AGTGATCTTC CCACCTCAGC CTCCCAAAGT GCTGAGATTA CAGGCATGCA 240
CCACTGCTCC CAGGTGAATC CAACTGTTTT CAACAAGTTT TCACTGCTTA CAGTATCTCA 300
TCTCTGCTGT TGCAAATCCT GTAAGGATTG GGACAAGATA TAAATATCAA ATAAAGCAAG 360
TCTGTGCCAG TCCTTTAAAG ATTGCTTAGT TAGAATTTTG TGGCAAGGTT TAACACGTAA 420
ACATTAAGTC TAGAACCAAA TGTTAAAGAA AGGAAGATAA CATTTATTTA ATATTATTAT 480
ATGCTGTGTT AGTTGCTTTA TATTGATGCT TGAAGATAGA TGGTATTACT GAGGTTTGTA 540
GAGGTTAAAA CTAGTAAGTG ATAAGAGTTG GGATTCAGTT TCTTGTCTTT TGGATTTCAA 600
AACAGACATT ATGCTCTGTA TATTGTCTAT GGAAGAAGTA ATGTCATGAA AAATGAAAGA 660
TTAAATTATG TTTCAGATTT TGGTGAAATC AGATATTAAA TGGCCGAAAG TTTCCTGATT 720
ATATGTTAAT TTATCCCTCA TCTATTTGGA GGACTAGGGA CAATGCTCCC ATTTTAAGTC 780
TAAAATTCTT AATGGCTTTA GGGTTTGAGT TACTTTCAGA GCTTTACTTT TACTTTTCTT 840
CTGAGTTCTT GAGACTTTTA AAACTTTGCA TTTATTGTGG CACATTTTTG TTTTACTTAG 900
TAAACTTATT TTAAAAATAT TTGCTTGTGC CTACTATGTG ACAGGCATTG TGCTAAAGGC 960
CTTTGCCATG ACCTGATTAA TTAAGGATAT AGATTCTTTT TTTATTTTTT ATTTTTTTTA 1020
CTCTCAGGAT ATGCTTAAGG ATATATATTA TTAAAACATC ATTTTTTAAT TACCCAAAAT 1080
ATTATAAACA TTGCTCTGAC CCTTATTTAT TAGTCTCTTG ATTTCTCTAA ACTTTCACTT 1140
TCATTTCTTC AGAGCCAAAT CACTCTCTTA CCACCCCGTA ATGAGTAGCT CTTGATACTG 1200
TAAAGAGACC ACATCCATTT TACTTCTGTC TGCATCTTGT GGAATATTAT ATCAACAATA 1260
AGAAATTTTA TTCATAATTA ATAAGTTTAG CTTGGCCTCA GTTATAGTAT GGTTTATTGT 1320
TTATCCTTCT GTATTTGAAG CAAACATAAA TAGAGAGGAC GTAAATTTAA TAATTTATAC 1380
AGTATGCTCC AGTCCCTGAC TGTTTACTTC AGCCAGTACT GCTTTCTCCT AGGCCTTTGC 1440
TCATGTGTTC TTCCCACTAT GCAGTTTCCA TAAATAACTT CCTGTTTTGT TTTTTAATGT 1500
CTACTTACTC TTTGTTTCAG TACACGTATC ATATGTGGGA CCGTCTTTGC TTTCTGTCTT 1560
TCCAGTTCGT CCACTCTGAC ACAGCATGTG TCAGAATCTC TTCCTTATTT TCATAACACC 1620
CTAGATATCC CTGTCATTGC TCTTACTGCA TTAACTTTTT TATTTGATAC GTTTTTGTCA 1680
TGAGAATGAG CTTCTGCAAG GAATTATCAT TTCTTTTTTA TCTTTATATT TTCATTGTGT 1740
AGCACAATAT TGGCAAACAG TAGAAGTCTG GTACATATTT GATGAATGCA CAATAAATGG 1800
CATTGATTTT TATGTTTATC ATTTTAAAAA CTTTAGAATA CAGCTTCTAA TTGTTTTGCT 1860
TATCATACAA TATTTATTTC AGGACTGTAT TATTCTTGTG AAAGACTCAT AGGTAGATTT 1920
TCTCTTAAAA TTGTGAAAAA GTTGTCAGAA GACATATTTA TATAATGATA TTCAAAGGCC 1980
ATGCCATGGT GAGATTTTTT TTCCCCTAAT CTCCACTGTT 2020
|
